Getting to Know the Abecma (ide-cel) CAR T Therapy
Getting to Know the Abecma (ide-cel) CAR T Therapy image
May 18, 2021 / 12:00PM - 01:00PM EDT
Relapsed/Refractory Myeloma Chapter

Event Description

Everyone has been hearing about the newly FDA-approved Abecma (ide-cel) CAR T therapy, but what is this treatment? Who qualifies for it? And how can you sign up? Hear from multiple myeloma specialist Dr. Nina Shah as she shares the practical side of the CAR T and answers your questions. 

Schedule & Agenda

person
Introductions
12:00PM
Audrey Burton-Bethke
Audrey welcomes everybody, shares the agenda for the event and introduces our featured speaker, Dr. Nina Shah. 
person
Presentation
12:05PM
Dr. Nina Shah
Dr. Nina Shah shares the practical side of the Abecma (ide-cel) CAR T Therapy, who qualifies for it, and how to sign up.
person
Q&A
12:35PM
Audience
Dr. Shah answers the audience's questions about her presentation and CAR T.

Speakers & Moderators

The panelist Jennifer Ahlstrom
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of Myeloma Crowd by HealthTree and the HealthTree Foundation.

Read Bio
The panelist Audrey Burton-Bethke
Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.

Read Bio
The panelist Nina Shah, MD
Nina Shah, MD

Dr. Nina Shah is a specialist in blood diseases who focuses on treating multiple myeloma, a type of cancer affecting certain cells in the bone marrow. Her areas of professional interest include the intersection of immunology and oncology as well as helping patients fight multiple myeloma by boosting their immune systems. Shah earned a bachelor's degree in cognitive neuroscience at Harvard University, followed by a medical degree from New York University School of Medicine. She completed a residency in internal medicine at Columbia University and a fellowship in hematology-oncology at the University of Texas MD Anderson Cancer Center. Shah belongs to the American Society of Clinical Oncology, American Society of Hematology and American Society for Transplantation and Cellular Therapy. She speaks Bengali and Spanish.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

+1 800 709 1113

email

Support@healthtree.org

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Legend Biotechnologies
Bristol Myers Squibb
Abbvie
Genentech
GSK
Janssen Oncology

Follow Us

facebook instagram twitter youtube

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation for Multiple Myeloma (formerly know as Myeloma Crowd) is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811

 https://www.guidestar.org/profile/45-5354811